Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-001 vs Minoxidil for Female Pattern Hair Loss
NCT06484881Phase 3Withdrawn
- Start
- Sep 2024
- Primary completion
- Oct 2024
01
Overview
Phase 3, randomised, triple-blind trial (2 arms). Primary endpoint: Target Area Hair Counts at 12 weeks. Planned start Sep 2024; status: withdrawn.
Beyond the preview
Go deeper on NCT06484881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06484881.